FDA Offers Advice on Control of Nitrosamines in Drugs By Sam | October 6, 2020 The FDA released a straight-to-final guidance on steps drugmakers should take to prevent high levels of nitrosamine impurities in their products. Source: Drug GMP Report Posted in Drug GMP Report